Valeria Tavares

Gondomar, 4420096, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Vitamin D Receptor rs731236 Polymorphism Modulates Cancer Cachexia Susceptibility and Overall Survival: A Real-World Study on Context-Dependent Vitamin D Signalling.

Vitamin D Receptor rs731236 Polymorphism Modulates Cancer Cachexia Susceptibility and Overall Survival: A Real-World Study on Context-Dependent Vitamin D Signalling.

Journal: International journal of molecular sciences

Published: June 09, 2026

Correction: Heparanase (HPSE) genetic variants as prognostic indicators in ovarian cancer: evidence from discovery and validation cohorts.

Correction: Heparanase (HPSE) genetic variants as prognostic indicators in ovarian cancer: evidence from discovery and validation cohorts.

Journal: Molecular biology reports

Published: June 03, 2026

IGF-1 axis: The signalling bond in cancer-associated thrombosis and cachexia?

IGF-1 axis: The signalling bond in cancer-associated thrombosis and cachexia?

Journal: Journal of thrombosis and thrombolysis

Published: April 07, 2026

Prevention of Venous Thromboembolism in Patients with Ovarian Cancer: The State of the Research.

Prevention of Venous Thromboembolism in Patients with Ovarian Cancer: The State of the Research.

Journal: International journal of women's health

Published: April 02, 2026

Genetic Variability in the IGF-1 Axis Modulates Cancer-Associated Cachexia and Prognosis.

Genetic Variability in the IGF-1 Axis Modulates Cancer-Associated Cachexia and Prognosis.

Journal: Cancers

Published: March 30, 2026

Heparanase (HPSE) genetic variants as prognostic indicators in ovarian cancer: evidence from discovery and validation cohorts.

Heparanase (HPSE) genetic variants as prognostic indicators in ovarian cancer: evidence from discovery and validation cohorts.

Journal: Molecular biology reports

Published: February 05, 2026

The impact of genetic variants of the IGF-1 axis on surgical outcomes and prognosis in ovarian cancer.

The impact of genetic variants of the IGF-1 axis on surgical outcomes and prognosis in ovarian cancer.

Journal: Molecular biology reports

Published: December 10, 2025

ACE2 genetic polymorphisms and non-genetic factors were associated with a history of musculoskeletal injuries in high-performance athletes.

ACE2 genetic polymorphisms and non-genetic factors were associated with a history of musculoskeletal injuries in high-performance athletes.

Journal: Journal of sports sciences

Published: November 14, 2025

Endothelial dysfunction markers in cervical cancer and their influence on patient outcome.

Endothelial dysfunction markers in cervical cancer and their influence on patient outcome.

Journal: Molecular biology reports

Published: September 12, 2025

Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior.

Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior.

Journal: International journal of molecular sciences

Published: August 29, 2025

Non-coding RNAs and liquid biopsies: Emerging biomarkers for cervical cancer.

Non-coding RNAs and liquid biopsies: Emerging biomarkers for cervical cancer.

Journal: Critical reviews in oncology/hematology

Published: May 27, 2025

Genetic markers of thrombophilia as predictors of outcome in colorectal cancer.

Genetic markers of thrombophilia as predictors of outcome in colorectal cancer.

Journal: Journal of thrombosis and thrombolysis

Published: April 28, 2025

Showing 1-12 of 44

Last Updated: 09/26/2026